| Industry Range | | Price / Earnings | N/A | |
| Book Value | -0.05 | |
| Earnings Per Share | -$0.17 | |
| Price To Sales Ratio | 3.14 | |
| Price To Book Ratio | 2.1K | |
| Price To Tangible Book Ratio | N/A | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 409.2M | |
| Float (MRQ) | 65.82% | |
| Shares Outstanding (MRQ) | 111.6M | |
| Short Interest as a % of Float (MRQ) | 3.31% | |
| Shares Held By Institutions (MRQ) | 26.5M | |
| Industry Range | | Sales | $257.5M | |
| Gross Margin | 82.79% | |
| Net Profit Margin | -4.81% | |
| EBIT Margin | -2.89% | |
| EBITDA Margin | -0.61% | |
| Operating Margins | -2.89% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 3.47 | |
| Quick Ratio (MRQ) | 3.20 | |
| Total Debt/Equity Ratio (MRQ) | 56.71 | |
| Debt/Common Equity Ratio (MRQ) | N/A | |
| Industry Range | | Return on Equity | -14.18% | |
| Return on Assets | -8.69% | |
| Asset Turnover | 1.81 | |
| Receivables Turnover | 6.60 | |
| Inventory Turnover | 3.86 | |
| Industry Range | | EPS Growth Annual | -79.27% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*MDXG does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 1.53%